Stay updated on Pembrolizumab with CyBorD in NDMM Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with CyBorD in NDMM Clinical Trial page.

Latest updates to the Pembrolizumab with CyBorD in NDMM Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added to the Record History. The deletions remove a government-funding notice and the earlier Revision: v3.4.1 from the history.SummaryDifference0.8%

- Check21 days agoChange DetectedA government funding notice was added at the top of the page, and a new release note 'Revision: v3.4.1' was posted. The previous release note 'Revision: v3.4.0' was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check28 days agoChange DetectedThe Record History page now includes a glossary toggle and color-coded diffs (green for additions, red for deletions). The revision note is updated to v3.4.0 and the No FEAR Act data reference is removed.SummaryDifference1%

- Check42 days agoChange DetectedA new site revision, v3.3.4, was added to the release notes, replacing the previous revision v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedIn the Record History, a new entry 'Revision: v3.3.3' was added, and the items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed. These updates relate to site/version metadata rather than the study content.SummaryDifference0.2%

- Check85 days agoChange DetectedThe history now includes Revision: v3.3.2 and removes Revision: v3.3.1 from the list.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with CyBorD in NDMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with CyBorD in NDMM Clinical Trial page.